NCT02906397 · Interventional trial
Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)
Overall registry status Completed
Phase 1
Conditions ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory